In patients with type 2 diabetes and hyperlipidemia or mixed dyslipidemia on a maximally tolerated statin treatment with evolocumab lowers lowdensitylipoprotein cholesterol LDLC and improves levels of other lipids researchers say. Reuters Health Informat...
↧